Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Pharma
Lilly, Innovent's mazdutide nabs first-in-class nod in China
With a Chinese green light in obesity, Innovent and Eli Lilly's mazdutide has become the world's first commercial dual GLP-1/glucagon receptor agonist.
Fraiser Kansteiner
Jun 27, 2025 11:16am
RemeGen, Harbour, Datroway—Fierce Pharma Asia
Jun 27, 2025 8:37am
Novo Nordisk questioned over Spanish obesity awareness campaign
Jun 25, 2025 10:05am
Fierce Healthcare
Hims & Hers stock drops 30% after Novo Nordisk terminates deal
Jun 23, 2025 12:00pm
Lilly fills out lineup of Zepbound doses on self-pay website
Jun 16, 2025 11:48am
PD-1 bispecifics, Enhertu, Regeneron-Hansoh—Fierce Pharma Asia
Jun 6, 2025 7:15am